Evidence map›Paper›PMID 32801732›Full record

ReviewJournal of multidisciplinary healthcare2020

Systemic Solutions for Addressing Non-Communicable Diseases in Low- and Middle-Income Countries.

Aakash Ganju, Alessandra C Goulart, Amrit Ray, Anurita Majumdar, Barrett W Jeffers, Gloria Llamosa, Henry Cañizares, Ianne Jireh Ramos-Cañizares, Ibtihal Fadhil, Kannan Subramaniam and 9 more

Abstract readReview
In one paragraph

Review in Journal of multidisciplinary healthcare, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Aakash GanjuExecutive Office, Saathealth, Mumbai, India.ORCID 0000-0001-9547-4046
Alessandra C GoulartCenter for Clinical and Epidemiological Research, University Hospital, University of São Paulo, São Paulo, Brazil.ORCID 0000-0003-1076-5210
Amrit RayResearch, Development and Medical, Upjohn - a Pfizer Division, New York, NY, USA.ORCID 0000-0002-7902-2370
Anurita MajumdarResearch, Development and Medical, Emerging Markets, Upjohn - a Pfizer Division, Singapore.
Barrett W JeffersResearch, Development and Medical, Upjohn - a Pfizer Division, New York, NY, USA.
Gloria LlamosaMexican Neurology and Psychiatry Society, Mexico City, Mexico.ORCID 0000-0002-5721-3360
Henry CañizaresVicente Sotto Memorial Medical Center, Cebu City, Philippines.ORCID 0000-0001-6375-6997
Ianne Jireh Ramos-CañizaresVicente Sotto Memorial Medical Center, Cebu City, Philippines.ORCID 0000-0002-1020-626X
Ibtihal FadhilEastern Mediterranean NCD Alliance, Kuwait City, Kuwait.
Kannan SubramaniamResearch, Development and Medical, Upjohn - a Pfizer Division, Sydney, Australia.ORCID 0000-0001-5551-4103
Lee-Ling LimDepartment of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Luna El BizriSchool of Pharmacy, Lebanese University, Hadath, Lebanon.ORCID 0000-0001-9317-2132
M RameshLee Kuan Yew School of Public Policy, National University of Singapore, Singapore.ORCID 0000-0002-7376-2300
Mathew GuilfordExecutive Office, Common Health, Kuala Lumpur, Malaysia.
Raghib AliPublic Health Research Center, New York University, Abu Dhabi, United Arab Emirates.
Ratna Duddi DeviExecutive Office, DakshamA Health and Education, Gurgaon, India.ORCID 0000-0002-9817-3836
Rayaz A MalikWeill Cornell Medicine, Doha, Qatar.ORCID 0000-0002-7188-8903
Shekhar PotkarResearch, Development and Medical, Upjohn - a Pfizer Division, Dubai, United Arab Emirates.
Yuan-Pang WangInstituto de Psiquiatria (LIM-23), Hospital das Clinicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.ORCID 0000-0001-7076-8312

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-communicable diseases (NCDs) have been on the rise in low- and middle-income countries (LMICs) over the last few decades and represent a significant healthcare concern. Over 85% of "premature" deaths worldwide due to NCDs occur in the LMICs. NCDs are an economic burden on these countries, increasing their healthcare expenditure. However, targeting NCDs in LMICs is challenging due to evolving health systems and an emphasis on acute illness. The major issues include limitations with universal health coverage, regulations, funding, distribution and availability of the healthcare workforce, and availability of health data. Experts from across the health sector in LMICs formed a Think Tank to understand and examine the issues, and to offer potential opportunities that may address the rising burden of NCDs in these countries. This review presents the evidence and posits pragmatic solutions to combat NCDs.

Indexed as

low- and middle-income countriesmultisectoralnon-communicable diseasespublic–private partnershipuniversal health coverage

Identifiers

PMID32801732
PMCPMC7394587

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.